Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Nephrology

Building and Coordinating Your Care Team

At a Glance

TINU syndrome needs coordinated follow-up because kidney and eye inflammation can change at different times. Kidney and eye specialists, together with a coordinating doctor, should share records, medication plans, testing, and relapse monitoring.

Managing TINU syndrome requires effective coordination of care. Because the disease affects two completely different organ systems, your care involves specialists who must communicate regularly to ensure that the treatment for your eyes doesn’t negatively impact your kidneys, and vice versa [1][2].

The Care Team

Your core care team should include these specialists:

  • Nephrologist: A kidney specialist who monitors your serum creatinine, blood pressure, and urine markers (like beta-2-microglobulin) to track how your kidneys are recovering from inflammation [3][4].
  • Ophthalmologist: While a general ophthalmologist with experience in inflammation can appropriately manage uncomplicated anterior uveitis, you may be referred to a uveitis specialist (an ophthalmologist with extra training in inflammatory eye diseases) if your disease is complex, recurrent, or involves the back of the eye [2][5].
  • The Coordinator: Clarify which doctor is taking the lead locally. This is usually your Primary Care Physician (PCP) or Pediatrician. They play a vital role in “connecting the dots” between specialists and monitoring your overall health and growth while you are on potent medications [1][2].
  • Rheumatologist (Optional): If your case is complex or requires “steroid-sparing” medications like biologics, a rheumatologist may join the team to help manage these powerful immune-system drugs [6][7].

Preparing for Your First Specialist Visit

The first consultation with a specialist is an opportunity to clarify your diagnostic timeline. To make the most of this visit, you should bring the following physical records with you:

  1. Laboratory Trends: Do not just bring your latest result; bring a dated history of your blood and urine tests. Specialists need to see the “curve” of your creatinine and urinary beta-2-microglobulin over time [8][4].
  2. Biopsy Reports: If you had a kidney biopsy, bring the full pathology report. If possible, ask your hospital’s pathology department how to share the actual biopsy slides or digital images with your new specialist for a “second look” [9][10].
  3. Eye Imaging: Bring any previous OCT (Optical Coherence Tomography) scans or fluorescein angiography records if they were performed. These provide a baseline to see if your inflammation is improving or worsening [11][5].
  4. Medication Log: A precise list of every medication you have taken in the last six months, including doses and start/stop dates. This helps doctors evaluate potential medication associations [1][4].

What to Expect During the Evaluation

Your first comprehensive visit will likely be longer than a standard check-up. You should expect:

  • A Detailed History: The doctor will ask exactly when your eye symptoms started compared to your kidney symptoms. This timeline is crucial for a TINU evaluation [9][12].
  • A Full Dilated Eye Exam: The ophthalmologist will use drops to widen your pupils. They will check your intraocular pressure (IOP) and look at the very back of the eye for swelling of the optic nerve or retina [9][11].
  • Targeted Imaging and Testing: To ensure it isn’t a “look-alike” condition, the doctor may order specific targeted blood tests to rule out sarcoidosis, lupus (SLE), or infections like tuberculosis. If indicated by examination findings, they may also order an OCT scan to check for macular swelling. An invasive dye test like fluorescein angiography is not a universal screening tool, but may be used selectively for specific posterior-segment questions [13][4].

Clarifying the Plan

Because TINU requires ongoing management, it is encouraged to ask your doctors about how they will collaborate. You might ask:

  • “Which of you is the primary contact for adjusting my medication?”
  • “What is the most direct way to message the clinic if my symptoms change suddenly?”
  • “Can we build a one-page shared-care plan listing my current medicines and laboratory schedule?” [3][14]

Coordination is the most important part of your care. Since eye relapses are common even when the kidneys seem healthy, your team must remain vigilant together [3][15].

Common questions in this guide

Which doctors are usually involved in TINU syndrome care?
A nephrologist, or kidney specialist, monitors kidney function, blood pressure, and urine tests. An ophthalmologist, or eye specialist, manages uveitis, and a uveitis specialist may be involved when disease is complex or recurrent. A primary care doctor or pediatrician can coordinate the plan, while a rheumatologist may help with medicines that calm the immune system, including biologic treatments.
What should I bring to my first TINU specialist visit?
Bring dated blood and urine results, not just the most recent values, including creatinine and urinary beta-2-microglobulin if tested. Also bring any kidney biopsy report or available slides or images, previous OCT or fluorescein angiography records, and a six-month medication list with doses and start and stop dates.
What happens during a TINU evaluation?
Your doctor may review when eye and kidney symptoms began, perform a dilated eye examination, check eye pressure, and examine the back of the eye. Depending on the findings, testing may include blood tests for conditions such as sarcoidosis, lupus, or tuberculosis, plus OCT for suspected macular swelling; fluorescein angiography is used selectively rather than as a routine screen.
Can my eyes relapse after my kidney tests improve?
Yes. Eye inflammation can return even when kidney tests appear healthy, so normal kidney results do not necessarily mean eye follow-up can stop. Keep the long-term eye and kidney monitoring plan set by your clinicians.
Who should I contact if my TINU symptoms suddenly change?
Ask your team to name one primary contact, often your primary care doctor or pediatrician, and to give you a direct way to reach the clinic. Your shared plan should state when to contact the nephrologist or ophthalmologist directly for new eye or kidney symptoms.
How can my doctors coordinate TINU treatment?
Ask the team to keep a shared one-page plan listing current medicines, laboratory timing, upcoming eye exams, and who adjusts each medicine. Make sure each specialist receives updated results and medication changes so kidney and eye care can be balanced.

Get notified when new evidence is published on Tubulointerstitial nephritis and uveitis syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Fatigue, Polyuria, and Hidden Uveitis: A Case of Tubulointerstitial Nephritis and Uveitis Syndrome Diagnosed in Primary Care.

    Kerner M, Todoroff J, von Schnakenburg C, et al.

    Cureus 2025; (17(8)):e89245 doi:10.7759/cureus.89245.

    PMID: 40901228
  2. 2

    A Rare Case of Tubulointerstitial Nephritis and Uveitis Syndrome Treated with a Multi-Specialty Approach.

    Purt B, Hiremath S, Smith S, et al.

    The American journal of case reports 2016; (17()):869-873 doi:10.12659/ajcr.900701.

    PMID: 27867184
  3. 3

    Clinical outcomes in paediatric tubulointerstitial nephritis and uveitis syndrome (TINU).

    Mandel M, Elhusseiny AM, Davidson SL, et al.

    Eye (London, England) 2024; (38(17)):3318-3324 doi:10.1038/s41433-024-03286-9.

    PMID: 39085599
  4. 4

    [Clinical analysis of 4 children with tubulointerstitial nephritis and uveitis syndrome].

    Wang NN, Tu J, Chen CY

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2026; (64(11)):1274-1278 doi:10.3760/cma.j.cn112140-20260711-00547.

    PMID: 42876103
  5. 5

    Ocular manifestations and clinical outcomes in Tubulointerstitial Nephritis and Uveitis Syndrome (TINU).

    Uludag Kirimli G, Hassan M, Onghanseng N, et al.

    Eye (London, England) 2024; (38(2)):349-356 doi:10.1038/s41433-023-02695-6.

    PMID: 37626158
  6. 6

    Immunomodulation and TNF-α inhibition for tubulointerstitial nephritis and uveitis syndrome: a case series.

    Tirelli F, Shafer BM, Davidson SL, Lerman MA

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2021; (25(5)):267.e1-267.e6 doi:10.1016/j.jaapos.2021.03.017.

    PMID: 34600106
  7. 7

    TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS (TINU SYNDROME). A CASE REPORT.

    Kurašová E, Orság J, Klementa V, et al.

    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 2022; (78(6)):315-318 doi:10.31348/2022/31.

    PMID: 36543598
  8. 8

    Urinary β2-microglobulin and disease activity in patients with tubulointerstitial nephritis and uveitis syndrome.

    Provencher LM, Fairbanks AM, Abramoff MD, Syed NA

    Journal of ophthalmic inflammation and infection 2018; (8(1)):24 doi:10.1186/s12348-018-0166-3.

    PMID: 30594950
  9. 9

    Classification Criteria for Tubulointerstitial Nephritis With Uveitis Syndrome.

    American journal of ophthalmology 2021; (228()):255-261 doi:10.1016/j.ajo.2021.03.041.

    PMID: 33845023
  10. 10

    Tubulointerstitial Nephritis and Uveitis Syndrome: A Report of 6 Cases with Renal Biopsy and Electron Microscopy Evaluation.

    Palamaris K, Stylianou K, Destouni M, et al.

    Nephron 2024; (148(4)):204-214 doi:10.1159/000533402.

    PMID: 37611557
  11. 11

    Ultra-widefield Fluorescein Angiography and OCT Findings in Tubulointerstitial Nephritis and Uveitis Syndrome.

    Cao JL, Srivastava SK, Venkat A, et al.

    Ophthalmology. Retina 2020; (4(2)):189-197 doi:10.1016/j.oret.2019.08.012.

    PMID: 31708486
  12. 12

    Diagnostic and Management Strategies of Tubulointerstitial Nephritis and Uveitis Syndrome (TINU): Current Perspectives.

    Sanchez-Quiros J, Giralt L, Fonollosa A, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2023; (17()):2625-2630 doi:10.2147/OPTH.S404644.

    PMID: 37701464
  13. 13

    Tubulointerstitial nephritis and uveitis (TINU) syndrome: a case series.

    Farnan R, Stokes J, Casey R, et al.

    Journal of ophthalmic inflammation and infection 2025; (15(1)):55 doi:10.1186/s12348-025-00500-x.

    PMID: 40679561
  14. 14

    Tubulointerstitial nephritis and uveitis (TINU) syndrome and recent Streptococcus infection in a 9-year-old girl.

    Moreton RB, Fleck BW, Davidson J, Hughes D

    BMJ case reports 2020; (13(2)) doi:10.1136/bcr-2019-232077.

    PMID: 32071125
  15. 15

    Long-term outcome of biopsy-proven idiopathic tubulointersitial nephritis with or without uveitis in children-a nationwide follow-up study.

    Rytkönen S, Tainio J, Saarela V, et al.

    Pediatric nephrology (Berlin, Germany) 2021; (36(11)):3663-3671 doi:10.1007/s00467-021-05060-5.

    PMID: 34008125

This page is for informational purposes only and does not constitute medical advice. Your nephrologist, ophthalmologist, and coordinating clinician can tailor testing, medicines, and follow-up to your situation.